Skip to main content
James Eshleman Jr., MD, Pathology, Baltimore, MD

JamesRichardEshlemanJr.MD

Pathology • Baltimore, MD

Blood Banking & Transfusion Medicine, Anatomic Pathology, Clinical Pathology

Professor of Pathology, Professor of Oncology, Johns Hopkins University School of Medicine; Associate Director, Molecular Diagnostics Laboratory

Join to view full profile

Dr. Eshleman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Eshleman's full profile

Already have an account?

  • Office

    1800 Orleans Street
    Baltimore, MD 21287
    Phone+1 410-955-5000
    Fax+1 410-955-5001

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Blood Banking/Transfusion Medicine, 1992 - 1993
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1989 - 1992
  • Temple University Hospital
    Temple University HospitalInternship, Internal Medicine, 1988 - 1989
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1988

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1997 - 2026
  • PA State Medical License
    PA State Medical License 1992 - 2006
  • OH State Medical License
    OH State Medical License 1993 - 1998
  • American Board of Pathology Clinical Pathology

Publications & Presentations

PubMed

Journal Articles

  • Clinical Validation of Coexisting Driver Mutations in Colorectal Cancers  
    Junaid Ibrahim, James R Eshleman, Gang Zheng, Christopher D Gocke, Rena Xian, ScienceDirect

Press Mentions

  • FDA Clears Promega OncoMate™ MSI Dx Analysis System
    FDA Clears Promega OncoMate™ MSI Dx Analysis SystemJuly 28th, 2021
  • PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
    PD-1 Blockade in Tumors with Mismatch-Repair DeficiencyFebruary 10th, 2016

Grant Support

  • Identifying Familial Pancreatic Cancer Predisposition GenesNational Cancer Institute2012
  • Novel Human Cancer Cell Isolation SystemNational Cancer Institute2008–2011
  • Novel Tumor Suppressor Gene Discovery In Pancreatic CancerNational Cancer Institute2007–2008
  • Mutator Phenotypes In Microsatellite Stable Colon CancerNational Cancer Institute1999–2003
  • Mechanisms Underlying Genetic Defects In Colon CancerNational Cancer Institute1997–2000
  • Mechanisms Underlying Genetic Defects In Colon CancerNational Cancer Institute1996

External Links

Dr. James Eshleman, Dr. James Eshleman, MD, Dr. J Eshleman, Dr. James Richard Eshleman